Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Cirrhosis

Free Subscription Articles published in Gut Retrieve available abstracts of 66 articles: HTML format Text format

Single Articles

January 2012
1. FERREIRA CN , Rodrigues T, Cortez-Pinto H, Serejo F, et al
   The new definition of acute kidney injury in patients with cirrhosis: a critical look.
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. RIBERA J , Pauta M, Melgar-Lesmes P, Tugues S, et al
   Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.
   Gut. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. KRAG A , Wiest R, Albillos A, Gluud LL, et al
   The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease.
   Gut. 2012.
   PubMed     Text format     Related articles   
   
   
   
   December 2011
4. BOCKX I , Verdrengh K, Vander Elst I, van Pelt J, et al
   High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
   Gut. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. HENRIKSEN JH , Fuglsang S, Bendtsen F
   Fourier analysis of arterial pulse in patients with advanced cirrhosis indicates reduced wave reflections that may protect against manifest cardiac dysfunction.
   Gut. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
6. GLEESON D , McFarlane E, Dube A, Elphick DA, et al
   Comments on 'Early features of acute-on-chronic liver failure: a prospective cohort study'.
   Gut. 2011;60:1766.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
7. FRITH J , Fattakhova G, Jones DE, Henderson E, et al
   Cognitive impairment in non-cirrhotic chronic liver disease is unrelated to liver disease severity but associated with ineffective baroreflex function.
   Gut. 2011.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
8. LOPES JA , Melo MJ, Costa AC, Raimundo M, et al
   Acute kidney injury and in-hospital mortality in critically ill patients with cirrhosis: a cohort study.
   Gut. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. TSOCHATZIS EA , Manousou P, Fede G, Dhillon AP, et al
   Validating non-invasive markers of fibrosis: the need for a new histological reference standard.
   Gut. 2011;60:1442-3.
   PubMed     Text format     Related articles   
   
   
   
   August 2011
10. WONG F , Watson H, Gerbes A, Vilstrup H, et al
    Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. ABRAMOVITCH S , Dahan-Bachar L, Sharvit E, Weisman Y, et al
    Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
12. HAN G , Qi X, Guo W, Niu J, et al
    Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
13. STEIB CJ
    Kupffer cell activation and portal hypertension.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
14. ROSSLE M
    Hyperdynamic circulation and portal hypertension: chicken or egg?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
15. HOLLAND-FISCHER P , Gronbaek H, Sandahl TD, Moestrup SK, et al
    Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
16. THURSZ M , Brown A
    Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
17. MOLLER S , Hobolth L, Winkler C, Bendtsen F, et al
    Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. CASTERA L
    Screening the general population for cirrhosis using transient elastography: finding a needle in a haystack?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
19. CARDOSO AC , Carvalho-Filho RJ, Marcellin P
    Transient elastography in chronic viral hepatitis: a critical appraisal.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
20. LA MURA V , Reverter JC, Flores-Arroyo A, Raffa S, et al
    Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. HUTCHINSON JM , Davies MH
    The use of clonidine with diuretic therapy in the treatment of refractory ascites in patients with cirrhosis awaiting liver transplantation.
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
22. LUCA A , Miraglia R, Caruso S, Milazzo M, et al
    Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. WONG F , Nadim MK, Kellum JA, Salerno F, et al
    Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MOLEDA L , Trebicka J, Dietrich P, Gabele E, et al
    Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
25. KLUWE J , Wongsiriroj N, Troeger JS, Gwak GY, et al
    Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. PAPATHEODORIDIS GV , Manolakopoulos S, Touloumi G, Vourli G, et al
    Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET.Greec
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. EL-SERAG HB , Kramer JR, Chen GJ, Duan Z, et al
    Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    Gut. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. POWELL EE , Jonsson JR, Clouston AD
    Not every cell is as it seems: a role for ductular epithelial cells in fibrosis?
    Gut. 2011;60:1-2.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
29. CARDENAS A , Gines P
    Management of patients with cirrhosis awaiting liver transplantation.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
30. BERAZA N , Ofner-Ziegenfuss L, Ehedego H, Boekschoten M, et al
    Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. GRACIA-SANCHO J , Russo L, Garcia-Caldero H, Garcia-Pagan JC, et al
    Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. KALLIS YN , Robson AJ, Fallowfield JA, Thomas HC, et al
    Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. ROULOT D , Costes JL, Buyck JF, Warzocha U, et al
    Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. JALAN R , Mookerjee RP
    Acute-on-chronic liver failure: an early biopsy is essential?
    Gut. 2010;59:1455-6.
    PubMed     Text format     Related articles   
    
    
    
    
35. KATOONIZADEH A , Laleman W, Verslype C, Wilmer A, et al
    Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study.
    Gut. 2010;59:1561-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
36. AMITRANO L , Guardascione MA, Menchise A, Manguso F, et al
    Management of variceal haemorrhage in cirrhosis: the relevance of the risk stratification.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
37. SVEGLIATI-BARONI G , Faraci G, Fabris L, Saccomanno S, et al
    Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MALIK R , Schuppan D
    Serum fibrosis markers to predict clinical and histological progression in hepatitis C non-responders.
    Gut. 2010;59:1312-3.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
39. MAO Y , Yang H, Xu H, Lu X, et al
    Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. YANG YY , Lin HC, Lee WP, Chu CJ, et al
    Association of the G-protein and {alpha}2-adrenergic receptor gene and plasma norepinephrine level with clonidine improvement of the effects of diuretics in patients with cirrhosis with refractory ascites: a randomised clinical trial.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MCPHERSON S , Stewart SF, Henderson E, Burt AD, et al
    Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    Gut. 2010;59:1265-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. PARKES J , Roderick P, Harris S, Day C, et al
    Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease.
    Gut. 2010;59:1245-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. ALTAMIRANO J , Bataller R
    Cigarette smoking and chronic liver diseases.
    Gut. 2010;59:1159-62.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
44. GHITTONI G , Caturelli E, Rossi S
    Synchronous focal liver lesions in a patient with liver cirrhosis: commonplaces may be misleading.
    Gut. 2010;59:1155-6.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
45. FONTANA RJ , Dienstag JL, Bonkovsky HL, Sterling RK, et al
    Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. MUHANNA N , Tair LA, Doron S, Amer J, et al
    Amelioration of hepatic fibrosis by NK cell activation.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ZIPPRICH A , Kuss O, Rogowski S, Kleber G, et al
    Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Gut. 2010;59:963-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. MARRA F , Annunziato F
    Immunomodulation: a new approach to the therapy of cirrhosis?
    Gut. 2010;59:868-9.
    PubMed     Text format     Related articles   
    
    
    
    
49. CASTERA L , Pinzani M
    Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?
    Gut. 2010;59:861-6.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
50. PINZANI M
    The ELF panel: a new crystal ball in hepatology?
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
51. NALPAS B , Lavialle-Meziani R, Plancoulaine S, Jouanguy E, et al
    Interferon {gamma} receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. LORAS C , Gisbert JP, Minguez M, Merino O, et al
    Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LEYDEN JE , Looby S, Gulmann C, Patchett SE, et al
    Cryptogenic cirrhosis: or is it? An unusual case of portal hypertension.
    Gut. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
54. WORLICEK M , Knebel K, Linde HJ, Moleda L, et al
    Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. STEIB CJ , Hennenberg M, Beitinger F, Hartmann AC, et al
    Amiloride reduces portal hypertension in rat liver cirrhosis.
    Gut. 2010;59:827-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. BYRNE EA , Katbamna R, Scott C, Blanshard C, et al
    Patients with m2 antibodies: what diagnosis and follow-up are they given?
    Gut. 2010;59:859.
    PubMed     Text format     Related articles   
    
    
    
    May 2010
57. ALBILLOS A , Nieto M, Ubeda M, Munoz L, et al
    The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.
    Gut. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. JUNG Y , Witek RP, Syn WK, Choi SS, et al
    Signals from dying hepatocytes trigger growth of liver progenitors.
    Gut. 2010;59:655-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
59. JENG WJ , Chu CM
    The relative role of viral load and metabolic factors in the risk of cirrhosis in chronic hepatitis B.
    Gut. 2010;59:558-9.
    PubMed     Text format     Related articles   
    
    
    
    
60. PRINCE MI , Ducker SJ, James OF
    Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations.
    Gut. 2010;59:508-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. BAGHDASARYAN A , Claudel T, Kosters A, Gumhold J, et al
    Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
    Gut. 2010;59:521-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. SVEGLIATI-BARONI G , De Minicis S
    HIV protein gp120 and chemokines receptor for liver fibrosis.
    Gut. 2010;59:428-9.
    PubMed     Text format     Related articles   
    
    
    
    March 2010
63. LIN IT , Bair MJ, Chen HL, Lee CH, et al
    Abdominal swelling in a patient with cirrhosis.
    Gut. 2010;59:406.
    PubMed     Text format     Related articles   
    
    
    
    February 2010
64. CHANG LC , Chung CS, Liu CJ, Kao JH, et al
    Metabolic syndrome on top of chronic hepatitis B: the more, the worse?
    Gut. 2010;59:276-7.
    PubMed     Text format     Related articles   
    
    
    
    September 2009
65. BRUNO R , Galastri S, Sacchi P, Cima S, et al
    The HIV Envelope Protein GP120 Modulates The Biology of Human Hepatic Stellate Cells: A Link Between HIV Infection and Liver Fibrogenesis.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2009
66. YUE HY , Yin C, Hou JL, Zeng X, et al
    Hepatocyte nuclear factor 4{alpha} attenuates hepatic fibrosis in rats.
    Gut. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: